Материал: Клинический протокол. ВРТ и искусственная инсеминация

Вестник дерматологии и венерологии. 2015;(2):130–8.

293.Шуршалина, А. В. Клинико-морфологические особенности хронического эндометрита у женщин с нарушением репродуктивной функции: дис. …д-ра мед. наук: 14.01.01 / Шуршалина Анна Владимировна. – М., 2007. – 280 с.

294.Шуршалина АВ. Роль хронического эндометрита в развитии патологии репродуктивной функции. Российский медицинский журнал. 2007;(4):25–7.

295.Cicinelli E, Matteo M, Tinelli R, Lepera A, Alfonso R, Indraccolo U, et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod [Internet]. 2015;30(2):323–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25385744

296.Romero R, Espinoza J, Mazor M. Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization? Fertil

297.Сухих Г, Шуршалина А. Хронический эндометрит. ГЭОТАР-Мед. Москва; 2010.

298.Khastgir G, Abdalla H, Thomas A, Korea L, Latarche L, Studd J. Oocyte donation in Turner’s syndrome: an analysis of the factors affecting the outcome. Hum Reprod [Internet]. 1997;12(2):279–85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9070711

299.Abir R, Fisch B, Nahum R, Orvieto R, Nitke S, Ben Rafael Z. Turner’s syndrome and fertility: current status and possible putative prospects. Hum Reprod Update [Internet]. 7(6):603–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11727869

300.Hovatta O. Ovarian function and in vitro fertilization (IVF) in Turner syndrome. Pediatr Endocrinol Rev [Internet]. 2012;9 Suppl 2:713–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22946282

301.SWYER GI. Male pseudohermaphroditism: a hitherto undescribed form. Br Med J [Internet]. 1955;2(4941):709–12. Available from: http://www.ncbi.nlm.nih.gov/pubmed/13250193

302.Hagman A, Loft A, Wennerholm U-B, Pinborg A, Bergh C, Aittomäki K, et al. Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: a Nordic cohort study. Hum Reprod [Internet]. 2013;28(6):1598–609. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23539610

303.Practice Committee of American Society For Reproductive Medicine. Increased maternal cardiovascular mortality associated with pregnancy in women with Turner syndrome. Fertil

304.Creatsas G, Deligeoroglou E, Tsimaris P, Pantos K, Kreatsa M. Successful pregnancy in a Swyer syndrome patient with preexisting hypertension. Fertil Steril [Internet]. 2011;96(2):e83--5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21782051

305.Morcel K, Camborieux L, Programme de Recherches sur les Aplasies Müllériennes, Guerrier

D. Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome. Orphanet J Rare Dis [Internet]. 2007;2:13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17359527

306.MORRIS JM. The syndrome of testicular feminization in male pseudohermaphrodites. Am J Obstet Gynecol [Internet]. 1953;65(6):1192–211. Available from: http://www.ncbi.nlm.nih.gov/pubmed/13057950

307.Committee on Adolescent Health Care. ACOG Committee Opinion No. 728: Müllerian

Agenesis: Diagnosis, Management, And Treatment. Obstet Gynecol [Internet]. 2018;131(1):e35--e42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29266078

308.Raziel A, Friedler S, Gidoni Y, Ben Ami I, Strassburger D, Ron-El R. Surrogate in vitro

165

fertilization outcome in typical and atypical forms of Mayer-Rokitansky-Kuster-Hauser syndrome. Hum Reprod [Internet]. 2012;27(1):126–30. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22052385

309.Wood EG, Batzer FR, Corson SL. Ovarian response to gonadotrophins, optimal method for oocyte retrieval and pregnancy outcome in patients with vaginal agenesis. Hum Reprod

310.Reichman DE, Laufer MR. Mayer-Rokitansky-Küster-Hauser syndrome: fertility counseling and treatment. Fertil Steril [Internet]. 2010;94(5):1941–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20172513

311.Reichman D, Laufer MR, Robinson BK. Pregnancy outcomes in unicornuate uteri: a review.

312.Chan YY, Jayaprakasan K, Tan A, Thornton JG, Coomarasamy A, Raine-Fenning NJ. Reproductive outcomes in women with congenital uterine anomalies: a systematic review. Ultrasound Obstet Gynecol [Internet]. 2011;38(4):371–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21830244

313.Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update [Internet]. 7(2):161–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11284660

314.Letterie GS. Management of congenital uterine abnormalities. Reprod Biomed Online

315.Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Uterine septum: a guideline. Fertil Steril [Internet]. 2016;106(3):530–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27235766

316.Venetis CA, Papadopoulos SP, Campo R, Gordts S, Tarlatzis BC, Grimbizis GF. Clinical implications of congenital uterine anomalies: a meta-analysis of comparative studies. Reprod

317.Dicker D, Ashkenazi J, Dekel A, Orvieto R, Feldberg D, Yeshaya A, et al. The value of hysteroscopic evaluation in patients with preclinical in-vitro fertilization abortions. Hum

318.Lavergne N, Aristizabal J, Zarka V, Erny R, Hedon B. Uterine anomalies and in vitro fertilization: what are the results? Eur J Obstet Gynecol Reprod Biol [Internet]. 1996;68(1– 2):29–34. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8886677

319.Brucker S, Rall K, Campo R, Oppelt P, Isaacson K. Treatment of Congenital Malformations. Semin Reprod Med. 2011 Mar;29(02):101–12.

320.Revel A. Defective endometrial receptivity. Fertil Steril [Internet]. 2012;97(5):1028–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22542142

321.Pasquier C, Daudin M, Righi L, Berges L, Thauvin L, Berrebi A, et al. Sperm washing and virus nucleic acid detection to reduce HIV and hepatitis C virus transmission in serodiscordant couples wishing to have children. AIDS [Internet]. 2000;14(14):2093–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11061649

322.Semprini AE, Macaluso M, Hollander L, Vucetich A, Duerr A, Mor G, et al. Safe conception

166

for HIV-discordant couples: insemination with processed semen from the HIV-infected partner. Am J Obstet Gynecol [Internet]. 2013;208(5):402.e1--9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23395921

323.Steenvoorden MMC, Cornelissen M, van Leeuwen E, Schuurman NM, Egberink HF, Berkhout B, et al. Integration of immunodeficiency virus in oocytes via intracytoplasmic injection: possible but extremely unlikely. Fertil Steril [Internet]. 2012;98(1):173–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22584022

324.Morgia F, Sbracia M, Schimberni M, Giallonardo A, Piscitelli C, Giannini P, et al. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization. Fertil Steril [Internet]. 2004;81(6):1542–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15193474

325.Janssens RM, Lambalk CB, Schats R, Schoemaker J. Successful in-vitro fertilization in a natural cycle after four previously failed attempts in stimulated cycles: case report. Hum

326.Pelinck MJ, Hoek A, Simons AHM, Heineman MJ. Efficacy of natural cycle IVF: a review of the literature. Hum Reprod Update [Internet]. 8(2):129–39. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12099628

327.Nargund G, Waterstone J, Bland J, Philips Z, Parsons J, Campbell S. Cumulative conception and live birth rates in natural (unstimulated) IVF cycles. Hum Reprod [Internet]. 2001;16(2):259–62. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11157816

328.Lenton EA. Natural cycle IVF with and without terminal HCG: learning from failed cycles. Reprod Biomed Online [Internet]. 2007;15(2):149–55. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17697489

329.Kadoch I-J, Phillips SJ, Bissonnette F. Modified natural-cycle in vitro fertilization should be considered as the first approach in young poor responders. Fertil Steril [Internet]. 2011;96(5):1066–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22036050

330.Ho JR, Paulson RJ. Modified natural cycle in in vitro fertilization. Fertil Steril [Internet]. 2017;108(4):572–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28965551

331.Shaulov T, Vélez MP, Buzaglo K, Phillips SJ, Kadoch IJ. Outcomes of 1503 cycles of modified natural cycle in vitro fertilization: a single-institution experience. J Assist Reprod

332.Rongières-Bertrand C, Olivennes F, Righini C, Fanchin R, Taïeb J, Hamamah S, et al.

Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophinreleasing hormone antagonist (Cetrorelix): a pilot study with minimal stimulation. Hum

333.Allersma T, Farquhar C, Cantineau AEP. Natural cycle in vitro fertilisation (IVF) for subfertile couples. Cochrane database Syst Rev. 2013;(8):CD010550.

334.Kamath MS, Kirubakaran R, Mascarenhas M, Sunkara SK. Perinatal outcomes after stimulated versus natural cycle IVF: a systematic review and meta-analysis. Reprod Biomed

335.Practice Committees of the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology. In vitro maturation: a committee opinion. Fertil Steril

167

http://www.ncbi.nlm.nih.gov/pubmed/23391409

336.Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian R-C, et al. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod Biomed Online [Internet]. 2010;21(4):566–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20822957

337.Chang EM, Song HS, Lee DR, Lee WS, Yoon TK. In vitro maturation of human oocytes: Its role in infertility treatment and new possibilities. Clin Exp Reprod Med [Internet]. 2014;41(2):41–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25045627

338.Hourvitz A, Maman E, Brengauz M, Machtinger R, Dor J. In vitro maturation for patients with repeated in vitro fertilization failure due to “oocyte maturation abnormalities”. Fertil

339.Tan S-L. [In vitro maturation: clinical and biological aspects]. J Gynecol Obstet Biol Reprod (Paris) [Internet]. 2003;32(3 Pt 2):S52--6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12773921

340.Fadini R, Dal Canto MB, Mignini Renzini M, Brambillasca F, Comi R, Fumagalli D, et al. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reprod Biomed Online [Internet]. 2009;19(3):343–

51.Available from: http://www.ncbi.nlm.nih.gov/pubmed/19778479

341.Chian RC, Buckett WM, Tulandi T, Tan SL. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod [Internet]. 2000;15(1):165–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10611207

342.Son W-Y, Chung J-T, Herrero B, Dean N, Demirtas E, Holzer H, et al. Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCGprimed in vitro maturation cycles. Hum Reprod [Internet]. 2008;23(12):2680–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18775885

343.Elizur SE, Son W-Y, Yap R, Gidoni Y, Levin D, Demirtas E, et al. Comparison of low-dose human menopausal gonadotropin and micronized 17beta-estradiol supplementation in in vitro maturation cycles with thin endometrial lining. Fertil Steril [Internet]. 2009;92(3):907–

12.Available from: http://www.ncbi.nlm.nih.gov/pubmed/18976750

344.Buckett WM, Chian R-C, Holzer H, Dean N, Usher R, Tan SL. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol [Internet]. 2007;110(4):885–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17906024

345.Fadini R, Mignini Renzini M, Guarnieri T, Dal Canto M, De Ponti E, Sutcliffe A, et al. Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles. Hum Reprod. 2012;27(12):3601–8.

346.Cakmak H, Rosen MP. Ovarian stimulation in cancer patients. Fertil Steril. 2013 May;99(6):1476–84.

347.Coyne K, Purdy M, Oâ€TMLeary K, Yaklic JL, Lindheim SR, Appiah LA. Challenges and Considerations in Optimizing Ovarian Stimulation Protocols in Oncofertility Patients. Front

348.Reddy J, Turan V, Bedoschi G, Moy F, Oktay K. Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin

168

(hCG) in breast cancer patients undergoing fertility preservation: an extended experience. J Assist Reprod Genet [Internet]. 2014;31(7):927–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24854484

349.Simon A, Laufer N. Repeated implantation failure: clinical approach. Fertil Steril [Internet]. 2012;97(5):1039–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22464086

350.Polanski LT, Baumgarten MN, Quenby S, Brosens J, Campbell BK, Raine-Fenning NJ.

What exactly do we mean by “recurrent implantation failure”? A systematic review and opinion. Reprod Biomed Online [Internet]. 2014;28(4):409–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24581986

351.Coughlan C, Ledger W, Wang Q, Liu F, Demirol A, Gurgan T, et al. Recurrent implantation failure: definition and management. Reprod Biomed Online [Internet]. 2014;28(1):14–38. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24269084

352.Корсак ВС, Смирнова АА, Шурыгина ОВ. Регистр центров ВРТ в России. Отчет за 2013г. Проблемы репродукции. 2015;21(6):16–32.

353.Корсак ВС, Смирнова АА, Шурыгина ОВ. Регистр центров ВРТ в России. Отчет за

2014г. Проблемы репродукции. 2016;22(5):8–21.

354.European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE), Calhaz-Jorge C, de Geyter C, Kupka MS, de Mouzon J, Erb K, et al. Assisted reproductive technology in Europe, 2012: results generated from European registers by ESHRE. Hum Reprod. 2016;31(8):1638–52.

355.Bradshaw KD, Guzick DS, Grun B, Johnson N, Ackerman G. Cumulative pregnancy rates for donor insemination according to ovulatory function and tubal status. Fertil Steril

356.Hammond MG, Jordan S, Sloan CS. Factors affecting pregnancy rates in a donor insemination program using frozen semen. Am J Obstet Gynecol [Internet]. 1986;155(3):480–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3752170

357.Chauhan M, Barratt CL, Cooke SM, Cooke ID. Differences in the fertility of donor insemination recipients--a study to provide prognostic guidelines as to its success and outcome. Fertil Steril [Internet]. 1989;51(5):815–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2707456

358.ESHRE Capri Workshop Group. Intrauterine insemination. Hum Reprod Update [Internet]. 15(3):265–77. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19240042

359.Cantineau AEP, Heineman MJ, Cohlen BJ. Single versus double intrauterine insemination in stimulated cycles for subfertile couples: a systematic review based on a Cochrane review.

360.Green KA, Zolton JR, Schermerhorn SM V, Lewis TD, Healy MW, Terry N, et al. Progesterone luteal support after ovulation induction and intrauterine insemination: an updated systematic review and meta-analysis. Fertil Steril [Internet]. 2017;107(4):924-- 933.e5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28238492

169